William G. Gilroy | June 21, 2013 | Notre Dame News
Research being carried out at the University of Notre Dame and its affiliated Harper Cancer Research Institute (HCRI) may lead to the development of a rapid, cost-effective means of screening for oral cancers and the human papillomavirus.
M. Sharon Stack, Ann F. Dunne and Elizabeth Riley Director of the HCRI and professor of chemistry and biochemistry, and Hsueh-Chia Chang, Bayer Professor of Engineering and director of Notre Dame’s Center for Microfluidics and Medical Diagnostics, are working on developing a microfluidic sensor to help detect the presence of tumor cells.